DIM
WST icon

DC Investments Management’s West Pharmaceutical WST Stock Holding History

DC Investments Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,552
Closed -$807K – 304
2020
Q2 		$807K Buy
3,552
+1,742
+96% +$342K 0.3% 40
2020
Q1 		$276K Buy
+1,810
New +$279K 0.22% 181
2018
Q1 		– Sell
-3,509
Closed -$346K – 340
2017
Q4 		$346K Buy
+3,509
New +$344K 0.14% 189

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

DC Investments Management's WST Position: Q3 2020 in Review

DC Investments Management sold out of West Pharmaceutical (WST) in Q3 2020, closing a stake of 3,552 shares — an estimated $807K sold.

DC Investments Management first reported a position in WST in Q4 2017 and held it in 3 quarters. The position peaked at $807K in Q2 2020. 574 funds tracked by Wall St. Rank hold WST as of Q3 2020.

  • DC Investments Management reported no remaining West Pharmaceutical position as of Q3 2020 after selling out during the quarter.
  • DC Investments Management sold 3,552 West Pharmaceutical shares in Q3 2020, an estimated $807K.
  • DC Investments Management first reported a position in West Pharmaceutical in Q4 2017 and held it in 3 quarters.
  • DC Investments Management's West Pharmaceutical position peaked at $807K in Q2 2020.
  • 574 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2020.

Based on DC Investments Management's 13F filing for Q3 2020, filed 4 Nov 2020.